Trefoil peptide TFF2 (spasmolytic polypeptide) potently accelerates healing and reduces inflammation in a rat model of colitis

Gut

Volumn 44, Issue 5, 1999, Pages 636-642

  Tran, C P ^c   Cook, G A ^c   Yeomans, N D ^c   Thim, L ^a   Giraud, A S ^b  

^a NOVO NORDISK A S   (Denmark)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c NONE

Author keywords

Colitis; Repair; Spasmolytic polypeptide; TFF2; Trefoil peptide

Indexed keywords

DINITROBENZENESULFONIC ACID; NITROBENZENE DERIVATIVE; SPASMOLYTIC AGENT; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL PROTECTION; COLITIS; CONTROLLED STUDY; DOSE RESPONSE; MALE; NONHUMAN; PEPTIDE ANALYSIS; PRIORITY JOURNAL; RAT; RECTAL DRUG ADMINISTRATION; STOMACH INJURY; TREATMENT OUTCOME; VALIDATION PROCESS; WOUND HEALING;

EID: 0002934088     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.44.5.636     Document Type: Article

References (39)

1. 1 Thim L. A new family of growth factor-like peptides. 'Trefoil' disulfide loop structures as a common feature in breast cancer associated peptide (pS2), pancreatic spasmolytic polypeptide (PSP), and frog skin peptides (spasmolysins). FEBS Lett 1989;250:85-90.
2. 2 Thim L. Trefoil peptides - from structure to function. Cellular and Molecular Life Sciences 1997;53:888-903.
3. 3 Poulsom R. Trefoil peptides. Bailliere's Clin Gastroenterol 1996;10:113-34.
4. 4 Sands BE , Podolsky DK. The trefoil peptide family. Ann Rev Physiol 1996;58:253-73.
5. 5 Masiakowski P, Breathnach R, Bloch J, et al. Cloning of cDNA sequences of hormone-regulated genes from the MCF-7 human breast cancer cell line. Nucleic Acids Res 1982;10:7895-903.
6. 6 Rio MC, Bellocq JP, Daniel JY, et al. Breast cancer-associated pS2 protein; synthesis and secretion by normal stomach mucosa. Science 1988;241:705-7.
7. 7 Hanby AM, Poulsom R, Singh S, et al. Spasmolytic polypeptide is a major antral peptide: distribution of the trefoil peptide human spasmolytic polypeptide and ps2 in the stomach. Gastroenterology 1993;105:1110-16.
8. 8 Jeffrey GP, Oates PS, Wang TC, et al. Spasmolytic polypeptide: a trefoil peptide secreted by rat gastric mucous cells. Gastroenterology 1994;106:336-45.
9. 9 Suemori S, Lynch-Devaney K, Podolsky DK. Identification and characterization of rat intestinal trefoil factor; tissue and cell-specific member of the trefoil protein family. Proc Natl Acad Sci USA 1991;88:11017-21.
10. 10 Podolsky DK, Lynch-Devaney K, Stow JL, et al. Identification of human intestinal trefoil factor. Goblet cell-specific expression of a peptide targeted for apical secretion. J Biol Chem 1993;268:6694-702.
11. 11 Hauser F, Roeben C, Hoffman W. xP2, a new member of the P-domain peptide family of potential growth factors, is synthesised in Xenopus laevis skin. J Biol Chem 1992;267: 14451-5.
12. 12 Hauser F, Hoffman W. xP1 and xP4. P-domain peptides expressed in Xenopus laevis stomach mucosa. J Biol Chem 1991;266:21306-9.
13. 13 Wright NA, Poulsom R, Stamp GW, et al. Epidermal growth factor (EGF/URO) induces expression of regulatory peptides in damaged human gastrointestinal tissues. J Pathol 1990;162:279-84.
14. 14 Rio M-C, Chenard M-P, Wolf C, et al. induction of pS2 and hSP genes as markers of mucosal ulceration of the digestive tract. Gastroenterology 1991;100:375-9.
15. 15 Wright NA, Poulsom R, Stamp G, et al. Trefoil peptide gene expression in gastrointestinal epithelial cells in inflammatory bowel disease. Gastroenterology 1993;104:12-20.
16. 16 Alison MR, Chinery R, Poulsom R, et al. Experimental ulceration leads to sequential expression of spasmolytic polypeptide, intestinal trefoil factor, epidermal growth factor and transforming growth factor-alpha messenger-RNAs in rat. J Pathol 1995;175:405-14.
17. 17 Tomita M, Itoh H, Ishikawa N, et al. Molecular cloning of mouse intestinal trefoil factor and its expression during goblet cell changes. Biochem J 1995;311:293-7.
18. 18 Itoh H, Tomita M, Uchino H, et al. cDNA cloning of rat pS2 peptide and expression of trefoil peptides in acetic acid-induced colitis. Biochem J 1996;318:939-44.
19. 19 Cook GA, Yeomans ND, Giraud AS. Temporal expression of trefoil peptides in the TGF-α knockout mouse after gastric ulceration. Am J Physiol 1997;272:G1540-9.
20. 20 Mashimo H, Wu DC, Podolsky DK, et al. Impaired defense of intestinal mucosa in mice lacking intestinal trefoil factor. Science 1996;274:262-5.
21. 21 Lefebvre O, Chenard MP, Masson R, et al. Gastric mucosa abnormalities and tumorigenesis in mice lacking the pS2 trefoil protein. Science 1996;274:259-62.
22. 22 Dignass A, Lynch-Devaney K, Kindon H, et al. Trefoil peptides promote epithelial migration through a TGF-β-independent pathway. J Clin Invest 1994;94:376-83.
23. 23 Playford RJ, Marchbank T, Chinery R, et al. Human SP is a cytoprotective agent that stimulates cell migration. Gastroenterology 1995;108:108-16.
24. 24 Babyatsky MW, DeBeaumont M, Thim L, et al. Oral trefoil peptides protect against indomethacin-induced gastric injury in rats. Gastroenterology 1996;110:489-97.
25. 25 Wallace JL, Le T, Carter L, et al. Hapten-induced chronic colitis in the rat: alternatives to trinitrobenzene sulfonic acid. J Pharmacol Toxicol Methods 1995;33:237-9.
26. 26 Morris GP, Beck PL, Herridge MS, et al. Hapten-induced model of chronic inflammation and ulceration in the rat. Gastroenterology 1989;96:795-803.
27. 27 Thim L, Norris K, Norris F, et al. Purification and characterization of the trefoil peptide human spasmolytic polypeptide (hSP) produced in yeast. FEBS Lett 1993;318: 345-52.
28. 28 Cook GA, Yeomans ND, Thim L, et al. Oral spasmolytic polypeptide is cytoprotective against aspirin induced injury in the rat stomach. J Gastroenterol Hepatol 1998;13:363-70.
29. 29 Wallace JL, Keenan CM. An orally active inhibitor of leukotriene synthesis accelerates healing in a rat model of colitis. Am J Physiol 1990;258:G527-34.
30. 30 Bradley PP, Priebat DA, Christensen RD, et al. Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. J Invest Dermatol 1982;78:206-9.
31. 31 Bradford M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding. Anal Biochem 1976;72:248-54.
32. 32 McKenzie C, Marchbank T, Playford R, et al. Pancreatic spasmolytic polypeptide protects the gastric mucosa but does not inhibit acid secretion or motility. Am J Physiol 1997;273:G112-17.
33. 33 Taupin DR, Cook GA, Yeomans ND, et al. Increased trefoil peptide expression occurs late in the healing phase in a model of gastric ulceration in the rat [abstract]. Gastroenterology 1994;106:A195.
34. 34 Kindon H, Pothoulakis C, Thim L, et al. Trefoil peptide protection of intestinal epithelial barrier function: cooperative interaction with mucin glycoprotein. Gastroenterology 1995;109:516-23.
35. 35 Cook GA, Yeomans ND, Giraud AS. Trefoil peptides show rapid cytoprotective effects against aspirin damage and may also regulate the inflammatory response by stimulating monocyte migration. J Gastroenterol Hepatol 1997;12 (suppl 1):A207.
36. 36 Ogata H, Podolsky DK. Trefoil peptide expression and secretion is regulated by neuropeptides and acetylcholine. Am J Physiol 1996;273:G348-54.
37. 37 Broughton-Smith NK, Wallace JL, Morris GP, et al. The effect of anti-inflammatory drugs on eicosanoid formation in a chronic model of inflammatory bowel disease in the rat. Br J Pharmacol 1988;94:65-72.
38. 38 Procaccino F, Reinshagen M, Hoffmann P, et al. Protective effect of epidermal growth factor in an experimental model of colitis in the rat. Gastroenterology 1994;107:12-17.
39. 39 Appleyard CB, Wallace JL. Re-activation of hapten-induced colitis and its prevention by anti-inflammatory drugs. Am J Physiol 1995;269:G119-25.